 |
Happiness Biotech Group Limited
HAPP
|
6.4 M |
- |
1.35 % |
$ 17.8 M |
China |
 |
AgeX Therapeutics
AGE
|
3.56 M |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
I-Mab
IMAB
|
576 M |
- |
- |
$ 866 M |
China |
 |
Deciphera Pharmaceuticals
DCPH
|
100 M |
- |
- |
$ 2.18 B |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B |
- |
- |
$ 40.3 B |
USA |
 |
Compugen Ltd.
CGEN
|
22.6 M |
$ 2.22 |
- |
$ 207 M |
Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Coherus BioSciences
CHRS
|
140 M |
$ 1.58 |
- |
$ 185 M |
USA |
 |
Athira Pharma
ATHA
|
47.5 M |
- |
- |
$ 269 M |
USA |
 |
Galera Therapeutics
GRTX
|
645 K |
- |
-32.59 % |
$ 7.61 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M |
- |
- |
- |
Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
9.38 M |
- |
- |
$ 231 M |
USA |
 |
Berkeley Lights
BLI
|
45.5 M |
- |
-7.31 % |
$ 87 M |
USA |
 |
Celldex Therapeutics
CLDX
|
51 M |
$ 29.93 |
- |
$ 1.99 B |
USA |
 |
Generation Bio Co.
GBIO
|
35.1 M |
- |
- |
$ 344 M |
USA |
 |
Akero Therapeutics
AKRO
|
39.8 M |
- |
- |
$ 3.67 B |
USA |
 |
Akouos
AKUS
|
16.8 M |
- |
0.23 % |
$ 488 M |
USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
9.02 M |
$ 0.79 |
- |
$ 36.1 M |
Israel |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M |
- |
- |
$ 7.46 M |
Israel |
 |
Esperion Therapeutics
ESPR
|
301 M |
$ 3.13 |
- |
$ 651 M |
USA |
 |
Eton Pharmaceuticals
ETON
|
38.5 M |
$ 28.9 |
- |
$ 778 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
1.33 M |
- |
-4.36 % |
$ 27 M |
USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
31 M |
- |
- |
$ 384 M |
Britain |
 |
Forte Biosciences
FBRX
|
20.8 M |
$ 16.69 |
- |
$ 216 M |
USA |
 |
Gracell Biotechnologies
GRCL
|
221 M |
- |
- |
$ 3.37 B |
China |
 |
Anika Therapeutics
ANIK
|
21.9 M |
$ 14.79 |
- |
$ 212 M |
USA |
 |
Advaxis
ADXS
|
25 M |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M |
- |
- |
$ 26.5 M |
USA |
 |
AIkido Pharma
AIKI
|
1.61 M |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.73 M |
$ 3.16 |
- |
$ 5.2 M |
Israel |
 |
Aptose Biosciences
APTO
|
9.31 M |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
CRISPR Therapeutics AG
CRSP
|
149 M |
$ 56.95 |
- |
$ 5.12 B |
Schweiz |
 |
Aptinyx
APTX
|
6.29 M |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Albireo Pharma
ALBO
|
45.3 M |
- |
-0.23 % |
$ 916 M |
USA |
 |
Galectin Therapeutics
GALT
|
8.03 M |
$ 2.38 |
- |
$ 152 M |
USA |